Malformaciones esqueléticas y alteraciones del crecimiento en fetos de ratas con diabetes moderada / Skeletal malformations and growth disturbances in fetuses of mild diabetic rats

Resumen Introducción. En la actualidad, la diabetes mellitus representa una de las condiciones médicas que complica el embarazo con mayor frecuencia, lo que afecta el crecimiento y el desarrollo fetal. Objetivo. Determinar las malformaciones esqueléticas y alteraciones en el crecimiento en fetos de ratas Wistar diabéticas. Materiales y métodos. Se utilizó un modelo de diabetes moderada inducida neonatalmente con estreptozotocina (STZ 100 mg/kg de peso corporal, por vía subcutánea) en ratas Wistar. En la adultez, las ratas sanas y diabéticas se aparearon con machos sanos de la misma edad y cepa. El día 20 de gestación se practicó la cesárea bajo anestesia. Se extrajeron los fetos, se pesaron y clasificaron como pequeños (PAG), adecuados (AEG) o grandes (GEG) para la edad gestacional. Los fetos seleccionados se procesaron para el análisis de anomalías esqueléticas y sitios de osificación. Resultados. En la descendencia de las ratas diabéticas, hubo un mayor porcentaje de fetos clasificados como pequeños o grandes y un menor porcentaje de fetos con peso adecuado; el promedio de peso fetal fue menor y había menos sitios de osificación. Se observaron alteraciones en la osificación de cráneo, esternón, columna vertebral, costillas y extremidades anteriores y posteriores; y también, hubo una correlación directa entre el peso y el grado de osificación fetal. Hubo malformaciones congénitas asociadas con la fusión y bifurcación de las costillas, así como cambios indicativos de hidrocefalia, como la forma de domo del cráneo, una amplia distancia entre los parietales y la anchura de las fontanelas anterior y posterior. Conclusión. La diabetes moderada durante la gestación altera el crecimiento y el desarrollo fetal, que se ve afectado tanto por macrosomía y la restricción del crecimiento intrauterino como por malformaciones esqueléticas.

Abstract Introduction: Currently, diabetes mellitus represents one of the medical conditions that more frequently complicates pregnancy affecting the fetus's growth and development. Objective: To determine the skeletal malformations and growth alterations in fetuses of diabetic Wistar rats. Materials and methods: We used a neonatally streptozotocin-induced mild diabetes model (STZ 100 mg/kg body weight - subcutaneously) in Wistar rats. In adulthood, healthy and diabetic rats were mated with healthy males of the same age and strain. On day 20 of gestation, a cesarean was performed under anesthesia. Fetuses were removed, weighed, and classified as small (SPA), adequate (APA), and large (LPA) for the gestational age. Selected fetuses were processed for skeletal anomaly and ossification sites analysis. Results: In the offspring of diabetic rats, there was a higher percentage of fetuses classified as small or large and a lower percentage of fetuses with adequate weight; the fetal weight mean was lower and there were fewer sites of ossification. Alterations were observed in the ossification of the skull, sternum, spine, ribs and fore and hind limbs; and also, there was a direct correlation between fetal weight and ossification degree There were congenital malformations associated with fusion and bifurcation of the ribs, as well as changes indicative of hydrocephaly, such as the dome shape of the skull, a wide distance between parietals, and the width of the anterior and posterior fontanels. Conclusion: Moderate diabetes during pregnancy alters fetal growth and development with macrosomia and intrauterine growth restriction, as well as skeletal malformations.

Judicialização da saúde: análise dos processos judiciais do medicamento lenalidomida impetrados contra a Secretaria de Saúde do Estado de São Paulo para tratamento de mieloma múltiplo / Health's judicialization: analysis of the law-suits of the drug lenalidomide filed against the Health Department of the State of São Paulo for the treatment of multiple myeloma

O Mieloma Múltiplo é uma neoplasia maligna que acomete a medula óssea, sendo comumente diagnosticado em idosos. Para o tratamento no Sistema Único de Saúde (SUS) seguem-se as Diretrizes Diagnósticas e Terapêuticas do Mieloma Múltiplo do Ministério da Saúde, de 2015. O medicamento lenalidomida é um análogo da talidomida. A talidomida e lenalidomida são indicados para tratamento do mieloma. Ambos medicamentos causam efeitos teratogênicos nos fetos. A lenalidomida teve seu registro sanitário aprovado pela Agência Nacional de Vigilância Sanitária (ANVISA) para uso no país em dezembro de 2017. Os pacientes que necessitam do tratamento com o medicamento lenalidomida ingressam com processos judiciais para obtê-lo visto não constar da lista de medicamentos fornecidos pelo SUS. A diferença de preço dos dois medicamentos à base de lenalidomida fabricados e disponíveis no mundo é extremamente alta (Lenalid® e Revlimid®). No Brasil, somente o medicamento Revlimid® teve seu registro de patente junto ao Instituto Nacional de Propriedade Industrial e seu registro sanitário deferido junto à ANVISA, sendo o único autorizado para a comercialização no país, pela regulamentação da RDC ANVISA 191/2017. Considerando a política de Assistência Oncológica no Sistema Único de Saúde, o presente trabalho visou descrever o perfil dos processos judiciais para fornecimento do medicamento lenalidomida utilizada tratamento de Mieloma Múltiplo por determinações judiciais contra a Secretaria de Estado da Saúde de São Paulo. O perfil dos processos analisados confirma o observado na literatura sobre a judicialização da saúde, que, apesar de heterogênea e com características regionais, em muitos estudos, observa-se maior participação de pacientes oriundos de unidades de saúde privadas e assistentes jurídicos majoritariamente de advogados particulares. Além disso, os dados detectados/encontrados demonstraram que os pacientes são residentes em municípios com alto grau de desenvolvimento, segundo o Índice de Desenvolvimento Humano Municipal (IDHM), o qual atua como um indicador que avalia três dimensões do desenvolvimento humano: longevidade, educação e renda. Constatou-se também, pelo perfil dos processos judiciais descritos, a predominância de pacientes do sexo masculino. Descreveram-se os aspectos de regulamentação e de controle sanitário do medicamento lenalidomida, em comparação à talidomida no Brasil, além das normativas da ANVISA vigentes sobre o controle da substância lenalidomida, diante dos riscos associados (segurança do paciente - teratogênese) e as questões relativas a patente e fenômeno de judicialização da saúde no país.

Multiple myeloma is a malignant neoplasm that affects the bone marrow and is com-monly diagnosed in the elderly. For treatment in the Unified Health System (SUS), the Ministry of Health's 2015 Myeloma Diagnostic and Therapeutic Guidelines are followed. The medication lenalidomide is an analogue of thalidomide. Thalidomide and lenalidomide are indicated for the treatment of myeloma. Both drugs have teratogenic effects on fetuses. Lenalidomide had its health record approved by the National Health Surveillance Agency (ANVISA) for use in the country in December 2017. Patients who need treatment with the drug lenalidomide file lawsuits to obtain it since it is not on the list of drugs provided by SUS. The price difference of the two lenalidomide-based drugs manufactured and available worldwide is extremely high (Lenalid® and Revlimid®). In Brazil, only the drug Revlimid® had its patent registra-tion with the National Institute of Industrial Property and its sanitary registration granted with ANVISA, being the only one authorized for commercialization in the country, by the regulation of RDC ANVISA 191/2017. Considering the policy of Onco-logical Assistance in the Unified Health System, the present study aimed to describe the profile of the legal proceedings for the supply of the drug lenalidomide used in the treatment of Multiple Myeloma due to judicial orders against the São Paulo State De-partment of Health. The profile of the analyzed cases confirms that observed in the literature on the judicialization of health, which, although heterogeneous and with re-gional characteristics, in many studies, there is a greater participation of patients from private health units and legal assistants mostly from private lawyers . In addition, the data detected / found showed that patients are residents of municipalities with a high degree of development, according to the Municipal Human Development Index (MHDI), which acts as an indicator that assesses three dimensions of human devel-opment: longevity, education and income. It was also verified, by the profile of the judicial processes described, the predominance of male patients. The regulatory and sanitary control aspects of the drug lenalidomide were described, in comparison to thalidomide in Brazil, in addition to the ANVISA regulations in force on the control of the lenalidomide substance, in view of the associated risks (patient safety - teratogenesis) and the relative issues the patent and phenomenon of judicialization of health in the country.

Efeitos tóxicos dos sedimentos do estuário do rio Capibaribe em embriões de zebrafish (Danio rerio) / Toxic effects of sediments of the Capibaribe estuary on zebrafish embryos (Danio rerio)

O presente estudo utilizou embriões de Danio rerio expostos aos elutriatos dos sedimentos estuarinos do rio Capibaribe, dos períodos chuvoso e seco, e analisou os efeitos letais, teratogênicos, bem como a frequência cardíaca. Os testes de toxicidade com os embriões seguiram as diretrizes da OECD 236. Mediante os resultados obtidos, a frequência cardíaca e a teratogenicidade foram os efeitos mais observados nos animais quando submetidos às amostras. Entre os efeitos teratogênicos, o retardo geral no desenvolvimento dos embriões foi o mais frequente durante as análises. Tais efeitos tóxicos se modificaram entre os pontos e entre os períodos de coleta. Essa variação de toxicidade pode estar relacionada à diversidade de atividades realizadas no entorno desse estuário, a influência do regime de chuvas, marés e correntes, indicando que a análise dos efeitos subletais e da teratogenicidade em embriões de D. rerio constitui bom parâmetro para avaliações de toxicidade de amostras ambientais.(AU)

The present study used Danio rerio embryos exposed to the elutriates of the estuarine sediments of the Rio Capibaribe, from the rainy and dry periods, where the lethal effects, teratogenic and heart rate were analyzed. Embryotoxicity tests followed the guidelines of OECD 236. Based on the results obtained, heart rate and teratogenicity demonstrated higher sensitivity to the samples. Among the teratogenic effects, the general delay in embryo development was the most frequent effect during the analyzes. These toxic effects changed between the points and between the collection periods. This variation of toxicity may be related to the diversity of activities carried out around this estuary, the influence of rainfall, tides, and currents, indicating the analysis of sublethal effects and teratogenicity in the D. rerio embryos are useful parameters for toxic evaluation of environmental samples.(AU)

Comparative toxicological analysis of Metformin (Biguanide) and Glibenclamide (Sulfonylureas), using Zebrafish Embryotoxicity Test (ZFET)

Background and Objective@#Type 2 (T2DM) and gestational diabetes mellitus (GDM) among pregnant Filipinos have been increasing over the years because of lifestyle westernization. While insulin has been the safe mainstay when dietary measures fail to maintain normoglycemia during pregnancy, recent studies have suggested oral hypoglycemic agents (OHAs) such as metformin and glibenclamide, may offer cheaper and efficacious alternatives. The problem however, is the passage of these drugs through the placenta which may pose possible danger towards the development of the growing embryo. The proposed study aims to evaluate and compare the embryotoxic and teratogenic potentials of the varying concentrations of the two PhilHealth covered oral hypoglycemic agents in the Philippines, namely metformin (biguanide) and glibenclamide (sulfonylureas). @*Methodology@#In this study, a comparison on embryotoxic potentials of metformin and glibenclamide was conducted using zebrafish embryotoxicity test (ZFET) across concentrations found in fetal (10, 20, 100, 500, 1000, 2000 μg/L) and maternal serum (10, 20, 100, 500, 1000, 2000 mg/L). @*Results and Conclusions@#Results revealed that metformin showed no significant (p>0.05) lethal effects, but revealed significant risk for teratogenicity, specifically decreased head and tail lengths and advanced hatching. Conversely, glibenclamide revealed significant potential for lethal (e.g., coagulation) and teratogenic effects including pericardial and yolk sac edema, spinal deformity and increased tail length. Comparative evaluation between the two OHAs reveal that glibenclamide has significantly (p<0.05) higher lethal and teratogenic effects. Together, our results suggest that the use of metformin over glibenclamide is favorable for safety testing in pregnant women suffering T2DM and GDM for the benefit of expanding treatment options for these diseases.

Molecular aspects of the teratogenesis of rubella virus

Rubella or German measles is an infection caused by rubella virus (RV). Infection of children and adults is usually characterized by a mild exanthematous febrile illness. However, RV is a major cause of birth defects and fetal death following infection in pregnant women. RV is a teratogen and is a major cause of public health concern as there are more than 100,000 cases of congenital rubella syndrome (CRS) estimated to occur every year. Several lines of evidence in the field of molecular biology of RV have provided deeper insights into the teratogenesis process. The damage to the growing fetus in infected mothers is multifactorial, arising from a combination of cellular damage, as well as its effect on the dividing cells. This review focuses on the findings in the molecular biology of RV, with special emphasis on the mitochondrial, cytoskeleton and the gene expression changes. Further, the review addresses in detail, the role of apoptosis in the teratogenesis process.

Malformações congênitas: principais etiologias conhecidas, impacto populacional e necessidade de monitoramento / Birth defects: main known etiologies, population impact and the need for monitoring

OBJETIVOS: Este artigo tem por objetivo revisar as causas, o impacto dos defeitos congênitos na morbimortalidade infantil e a importância da sua vigilância, bem como apresentar como nossa comunidade acadêmica está inserida neste monitoramento. MÉTODOS: Foi realizada uma revisão da literatura nas bases de dados Medline/PubMed e Scielo, incluindo publicações de janeiro de 2010 até maio de 2018, em português e inglês. As palavras-chave utilizadas foram: "birth defects", "etiology", "infant mortality", "teratogens", "congenital abnormalities", "defeitos congênitos", "ECLAMC", "genética". Foram incluídos também livros-textos e artigos relevantes na área, independente da data de publicação, assim como sites eletrônicos de relevância. Adicionalmente, descrevemos o funcionamento do programa de monitoramento de defeitos congênitos do Hospital São Lucas da PUCRS, vinculado ao Estudo Colaborativo Latino Americano de Malformações Congênitas (ECLAMC). RESULTADOS: 971 artigos foram localizados com as combinações das palavras-chave, destes 21 foram utilizados na revisão. No conteúdo da revisão incluímos as etiologias conhecidas dos defeitos congênitos, dentre elas, estão as genéticas, multifatoriais e teratógenos físicos, químicos e biológicos. Esses dados estão resumidos das tabelas 1 a 5 deste artigo. Com relação ao monitoramento de defeitos congênitos, o ECLAMC- PUCRS avaliou 3981 recém-nascidos no período de agosto de 2016 a dezembro de 2017, e a taxa observada de malformações foi de 3,77%. CONCLUSÃO: Os defeitos congênitos são uma causa importante de morbimortalidade em todos os países, inclusive no Brasil. A compreensão de suas etiologias contribui para o aconselhamento genético das famílias, para o estabelecimento do prognóstico e intervenções terapêuticas, assim como para sua prevenção.

OBJECTIVE: This article aims to review the impact of birth defects on infant morbidity and mortality and the importance of their surveillance, to review their causes, as well as to show how our academic community is included in this monitoring. METHODS: a literature review was conducted in the Medline / PubMed and Scielo databases, including publications from January 2010 to May 2018, in Portuguese and English. The keywords used were: "birth defects", "etiology", "infant mortality", "teratogens", "congenital abnormalities", "congenital defects", "ECLAMC", "genetics". Also included were textbooks and relevant articles in the area, regardless the date of publication, as well as relevant electronic sites. Additionally, we describe the operation of the congenital defect monitoring program of the São Lucas Hospital of PUCRS, linked to the Latin American Collaborative Study of Congenital Malformations (ECLAMC). RESULTS: 971 articles were found using the keywords, from those 21 were used in the review. In the content of the review we include the known etiologies of the congenital defects, among which are the genetic, multifactorial, and physical, chemical and biological teratogens. These data are summarized in Tables 1-5 of this article. With regard to the monitoring of congenital defects, ECLAMC-PUCRS evaluated 3981 newborns from August 2016 to December 2017, and the observed malformation rate was 3.77%. CONCLUSION: Congenital defects are an important cause of morbidity and mortality in all countries, including Brazil. Understanding their etiologies contributes to the genetic counseling of families, to the establishment of prognosis and therapeutic interventions, as well as to their prevention.

Malformações em pequenos ruminantes no semiárido da Bahia: aspectos epidemiológicos, clínico-patológicos e radiológicos / Malformations in small ruminants in the semi-arid region of Bahia: epidemiological, clinical-pathological and radiological aspects

O objetivo do presente trabalho é descrever os principais aspectos epidemiológicos, clínico-patológicos e radiológicos de malformações em pequenos ruminantes no semiárido do estado da Bahia. Foram realizadas visitas técnicas em 41 propriedades rurais no município de Uauá, Bahia, e em cada uma delas foi aplicado um questionário epidemiológico. Adicionalmente, quando se observavam casos de malformações, os animais eram avaliados vivos ou mortos. Foram necropsiados oito animais (1, 2, 3, 4, 5, 6, 7 e 8), e dois (7 e 8) foram submetidos a exame radiográfico. Sobre a alimentação do rebanho, 40 (97,56%) produtores rurais relataram o livre acesso de seus animais à vegetação nativa. Em relação à presença de Mimosa tenuiflora, 5 (12,2%) informaram que os animais tinham acesso à planta, 15 (36,6 %) disseram que tinham pouco contato, enquanto que 21 (51,2 %) relataram que não havia nenhum contato com a planta, pois essa espécie não estava presente em número relevante na região. Vinte e cinco dos 41 proprietários (60,98%) relataram o consumo de Poincianella pyramidalis. Foi constatado ainda que na maioria das propriedades havia muitas áreas invadidas por P. pyramidalis (80-90% da vegetação). As principais anormalidades relatadas pelos entrevistados em 36 propriedades foram artrogripose (87,80%), agnatia [22 (53,66%)], desvio lateral da mandíbula [11 (26,82%)], escoliose [6 (14,63%)], micrognatia [6 (14,63%)], fenda palatina [4 (9,75%)], crânio aumentado de tamanho [4 (9,75%)], microftalmia [2 (4,88%)], braquignatismo [1 (2,43%)], exoftalmia [1 (2,43%)] e deformidades múltiplas no crânio [1 (2,43%)]. No exame clínico de 13 animais com malformações, as principais alterações foram artrogripose bilateral dos membros torácicos (6/13); queilosquise (2/13); micrognatia (1/13) e má oclusão dentária (1/13). Considerando que algumas dessas malformações foram reproduzidas experimentalmente em caprinos pode-se sugerir P. pyramidalis como mais uma planta teratogênica para ruminantes no Nordeste do Brasil.(AU)

The aim of this paper is to describe the epidemiological, clinical-pathological and radiological aspects of malformations in small ruminants in the semi-arid state of Bahia. Technical visits were carried out in 41 rural properties in the city of Uauá, Bahia, and in each of them, an epidemiological questionnaire was applied. In addition, when malformations were observed, the animals were evaluated alive or dead. Eight animals (1, 2, 3, 4, 5, 6, 7 and 8) were necropsied, and two (7 and 8) were submitted to radiographic examination. Regarding the feeding of the herd, 40 (97.56%) farmers reported the free access of their animals to the native vegetation. Regarding the presence of Mimosa tenuiflora, 5 (12.2%) said that the animals had access to the plant, 15 (36.6%) was informed they had little contact, while 21 (51.2%) reported that there was no contact with the plant, because this species were not present in a relevant number in the region. Twenty five out of 41 owners (60.98%) reported the consumption of Poincianella pyramidalis. It was also verified that in the majority of the properties there were many areas invaded by P. pyramidalis (80-90% of the vegetation). The main abnormalities reported by the interviewees on 36 properties were arthrogryposis (87.80%), agnatia [22 (53.66%)], lateral deviation of the mandible [11 (26.82%)], scoliosis [6 (14.63%)], micrognathia [6 (14.63%)], cleft palate [4 (9.75%)], skull enlarged in size [4 (9.75%)], microphthalmia [2 (4.88%)], braquignatism [1 (2.43%)], exophthalmia [1 (2.43%)] and, multiple deformities in the skull [1 (2.43%)]. In the clinical examination of 13 animals with malformations, the main alterations were bilateral arthrogryposis of the thoracic limbs (6/13); cleft lip (2/13); micrognathia (1/13) and dental malocclusion (1/13). Considering that some of these malformations were reproduced experimentally in goats, it is possible to suggest P. pyramidalis as another teratogenic plant for ruminants in Northeast Brazil.(AU)

Teratogenicity of Antiepileptic Drugs

OBJECTIVE: Antiepileptic drugs (AED) have chronic teratogenic effects, the most common of which are congenital heart disease, cleft lip/palate, urogenital and neural tube defects. The aim of our study is to examine teratogenic effects of AED and the correlation between these malformations and AED in single or multiple pregnancies. METHODS: This is a retrospective study of malformations in children born to mothers currently followed up by our outpatient clinics who used or discontinued AED during their pregnancy. Their children were then investigated using echocardiography, urinary ultrasound, cranial magnetic resonance image, and examined by geneticists and pediatric dentists. RESULTS: One hundred and seventeen children were included in the study. Ninety one of these children were exposed to AED during pregnancy. The most commonly used AED were valproic acid and carbamazepine in monotherapy. The percentage of major anomaly was 6.8% in all children. Dysmorphic features and dental anomalies were observed more in children exposed especially to valproic acid. There were 26 mothers with two and four mothers with three pregnancies from the same fathers. No correlation was found between the distribution of malformations in recurring pregnancies and AED usage. CONCLUSION: Our study has the highest number of dysmorphism examined in literature, found in all the children exposed to valproic acid, which may account for the higher rate of facial dysmorphism and dental anomalies. On lower doses of valproic acid, major malformations are not seen, although the risk increases with polytherapy. Our data also indicate possible effects of genetic and environmental factors on malformations.

Maternal and fetal toxicity of Wistar rats exposed to herbicide metolachlor / Toxicidade materna e fetal de ratas Wistar expostas ao herbicida metolacloro

Metolachlor is a selective pre-emergent herbicide widely used in agriculture to control weeds. The aim of this study was to evaluate the possible effects of metolachlor on reproductive performance of adult rats, as well as its teratogenic potential when administered during the period of organogenesis. Pregnant adult female rats were allocated into 4 experimental groups (n = 10 group-1), that received 0 (control); 150 (TA); 300 (TB); or 1000 mg kg-1 bw day-1 (TC) of metolachlor, by gavage, from the 6th to 15th gestational day (GD). There is reduction in the weight gain of the animals from TB and TC groups compared to the control group. Liver and placenta weights were reduced in TB and TC groups, respectively, while the percentage of post-implantation loss was increased in the TC group. There were no external malformations in either rat of the control or treated groups. However, an increased incidence of skeletal anomalies and visceral anomalies (especially in the urogenital system) was observed in TC group. These results demonstrate that exposure of pregnant rats to metolachlor can lead to signs of general toxicity, late embryonic losses and congenital anomalies.

O metolacloro é um herbicida seletivo de pré-emergência, amplamente usado na agricultura para controlar ervas daninhas. O objetivo deste estudo foi avaliar os possíveis efeitos do metolacloro sobre o desempenho reprodutivo de ratas adultas, bem como o seu potencial teratogênico quando administrado durante o período da organogênese. Ratas adultas prenhes foram divididas em quatro grupos experimentais (n = 10 grupo-1), que receberam 0 (controle); 150 (TA); 300 (TB); ou 1.000 mg kg-1 dia-1 (TC) do metolacloro, via gavagem, do sexto ao 15º dia de gestação (DG). Foi observada redução no ganho de peso dos animais dos grupos TB e TC em comparação ao grupo controle. Os pesos do fígado e placenta foram reduzidos nos grupos TB e TC, respectivamente, enquanto que a percentagem de perda pós-implantação foi aumentada no grupo TC. Não foram observadas malformações externas nos ratos dos grupos controle e tratados. No entanto, foi observado aumento da incidência de anomalias esqueléticas e anomalias viscerais (especialmente no sistema urogenital) no grupo TC. Estes resultados demonstram que a exposição de ratas prenhes ao metolacloro pode levar a sinais de toxicidade geral, perdas embrionárias tardias e anomalias congênitas.

Capacidad antiteratogénica del resveratrol en diabetes inducida por estreptozotocina en ratas / Antiteratogenic capacity of resveratrol in streptozotocin-induced diabetes in rats

Evaluar la capacidad antihiperglucémica y antiteratogénica del resveratrol en ratas inducidas a diabetes por estreptozotocina. Materiales y métodos. Estudio de tipo experimental. Se tuvieron tres grupos, de cinco ratas Wistar preñadas cada uno, dos de los cuales fueron tratados el cuarto día de gestación con una dosis de estreptozotocina de 50 mg/kg, disuelta en tampón de citratos, y el otro fue considerado como control, y solo se le administró el tampón de citratos. A uno de los grupos inducidos con estreptozotocina se le administró resveratrol a dosis de 100 mg/kg durante los días 8 al 12 de gestación, cuando sucede la neurulación. Los fetos se obtuvieron el día 19 de gestación y se les realizó un análisis morfológico, y en el hígado fetal se determinó la actividad de las enzimas depuradoras de especies reactivas catalasa, superóxido dismutasa y glutatión peroxidasa. Resultados. La administración de resveratrol (DM+R) revierte los parámetros a valores similares a los del grupo control. Las actividades de catalasa y de glutatión peroxidasa, se vieron incrementadas en el grupo tratado con resveratrol con respecto al grupo diabético, en cuanto a la frecuencia de malformaciones en el grupo control y en el grupo tratado con resveratrol no presentaron malformaciones, mientras que en las ratas con diabetes inducida, se encontró una elevada frecuencia de malformaciones. Conclusiones. El resveratrol muestra propiedades antiteratogénicas a través de la disminución del estrés oxidativo que se presenta a causa de la hiperglucemia materna...

To evaluate the anti-hyperglycemic and anti-teratogenic capacity of resveratrol in streptozotocin-induced diabetic rats. Material and methods. Experimental study. There were three groups, of five rats each; two groups were treated with a single dose of 50 mg/Kg of streptozotocin (STZ), in citrate buffer, at the 4th day of gestation, and the third group was considered the control, and were administered with citrate buffer only. One of the two STZ induced groups was administered with 100 mg/Kg resveratrol the days 8th to 12th, when neurulation occurs. Fetuses were obtained the 19th gestational day, and were subjected to morphologic analysis; and in fetal liver the activities of scavenging enzymes catalase, superoxide dismutase and gluthathione peroxidase were measured. Results. Resveratrol can decrease the teratogenic effect of STZ-induced diabetes, and scavenging activities were beneficed by the administration of this antioxidant. Conclusion. Resveratrol shown embryoprotective properties mediated by amelioration of oxidative stress produced by maternal hyperglycemia...

Exposure of pregnant rats to shortwave electromagnetic athermal radiation does not adversely affect their fetuses / Exposição de ratas prenhes a ondas curtas de radiação eletromagnética atérmica não afeta adversamente os seus fetos

BACKGROUND: The aim of this study was to determine whether shortwave electromagnetic radiation in pulsed mode with a frequency of 45 Hz, promotes teratogenic changes, stillbirths and changes in organ weight at birth in the fetuses of pregnant rats exposed to this radiation. METHOD: Ten black Macole pregnant female rats were studied, 5 in a test group, subjected to electromagnetic radiation with an average power of 4.5 W for 15 minutes, on a daily basis, during the entire period of pregnancy and 5 in a control group that was not exposed to radiation. At day 21, the animals were euthanized for analysis of fetuses. To assess the thermal effect of the radiation the abdominal temperature was measured before and after application, together with prevailing ambient temperature. The fetuses were evaluated through the Galant reflex to assess the existence of stillbirths. The fetuses were removed and weighed; through a midline laparotomy their hearts, stomachs, kidneys and livers were excised and weighed, wet and dry. Twenty-nine fetuses were harvested in the control group and 59 in the test group, with no cases of stillbirth, teratogenesis or malformation of internal organs. RESULTS: The analysis found no differences in birthweight and weight of dehydrated organs when compared to the control group. CONCLUSION: The results in our findings suggest that exposure to shortwave therapy without significant heat buildup, does not lead to teratogenic changes and did not affect the mass and weight of dehydrated internal organs.

RESUMO OBJETIVO: O objetivo deste estudo foi determinar se a radiação eletromagnética de ondas curtas em modo pulsado com uma frequência de 45 Hz, promove mudanças teratogênicos, natimortos, mudanças no peso do órgão ao nascimento em fetos de ratas grávidas expostas a essa radiação. METODO: Foram estudados dez ratas grávidas da raça Marcole, cinco num grupo teste, submetidas a radiação eletromagnética com uma potência média de 4,5W, durante 15 minutos, diariamente, durante todo o período da gravideze cinco num grupo controle, não expostas a radiação. No 21º dia, os animais foram sacrificados para análise dos fetos. Para avaliar o efeito da radiação térmica, a temperatura abdominal foi medida antes e depois da aplicação, em conjunto com a temperatura ambiente prevalente. Os fetos foram submetidos ao reflexo de Galant para avaliara existênciade natimortos. Os fetos foram removidos e pesados; através de uma laparotomia mediana seus corações, estômagos, rins e fígados foram extirpados e pesados, frescose secos. RESULTADOS: Vinte e nove fetos foram colhidos no grupo controle e 59 no grupo de teste, sem casos de natimortos, teratogênese ou malformação dos órgãos internos. A análise não encontrou diferenças no peso ao nascer e peso de órgãos desidratados quando comparados com o grupo controle. CONCLUSÃO: Os resultados sugerem que a exposição a terapia de ondas curtas, sem o acúmulo significativo de calor, não levou a alterações teratogênicos e não afetou o peso dos fetos ou o peso dos órgãos internos desidratados.

Comparison of teratogenecity induced by nano- and micro-sized particles of zinc oxide in cultured mouse embryos / 대한수의학회지

The increasing uses of zinc oxide nanoparticles (nZnO) in industrial and personal care products raise possible danger of using nZnO in human. To determine whether ZnO induces size-dependent anomalies during embryonic organogenesis, mouse embryos on embryonic day 8.5 were cultured for 2 days under 50, 100, and 150 microg of nZnO (< 100 nm) or micro-sized ZnO (mZnO; 80 +/- 25 microm), after which the morphological changes, cumulative quantity of Zn particles, and expressions of antioxidant and apoptotic genes were investigated. Although embryos exposed to 50 microg of ZnO exhibited no defects on organogenesis, embryos exposed to over 100 microg of ZnO showed increasing anomalies. Embryos treated with 150 microg of nZnO revealed significant changes in Zn absorption level and morphological parameters including yolk sac diameter, head length, flexion, hindbrain, forebrain, branchial bars, maxillary process, mandibular process, forelimb, and total score compared to the same dose of mZnO-treated embryos. Furthermore, CuZn-superoxide dismutase, cytoplasmic glutathione peroxidase (GPx) and phospholipid hydroperoxidase GPx mRNA levels were significantly decreased, but caspase-3 mRNA level was greatly increased in nZnO-treated embryos as compared to normal control embryos. These findings indicate that nZnO has severer teratogenic effects than mZnO in developing embryos.

Efeitos teratogênicos de Prosopis juliflora em ratos e análise da toxicidade das vagens / Teratogenic effects of Prosopis juliflora in rats and analysis of the toxicity of the pods

Objetivou-se com este estudo determinar os possíveis efeitos teratogênicos de Prosopis juliflora, verificar se existe perda da toxicidade entre vagens armazenadas e recém-coletadas e determinar se existe diferença de toxicidade entre as vagens coletadas em diferentes localidades. Trinta ratas prenhes da linhagem Wistar foram separadas, aleatoriamente, em cinco grupos: um controle (G1) e quatro experimentais (G2, G3, G4 e G5). Os animais dos grupos G2 e G3 foram alimentados com ração contendo 70% de vagens de P. juliflora recém-coletadas em dois municípios diferentes. Os grupos G4 e G5 foram alimentados com ração preparada com vagens das mesmas procedências, porém armazenadas por um período de 6 meses. O grupo controle recebeu ração sem vagens de P. juliflora. No grupo controle o número de malformações por ninhada (1,16 ± 0,98) foi significativamente menor do que os dos grupos experimentais (14,00 ± 2,96, 6,16 ± 2,22, 7,66 ± 2,94 e 4,66 ± 1,63 para os grupos G2, G3, G4 e G5, respectivamente) indicando que a planta é teratogênica. Não foram observadas diferenças significativas na frequência de malformações e no número de fetos nascidos entre os grupos que receberam vagens de diferentes localidades. No entanto, o número de malformações nos grupos que receberam as vagens recém-colhidas (65,80 ± 21,20 a, 67,59 ± 18,10 a), foi significativamente maior que o observado nas ratas que receberam as vagens após o armazenamento (35,74±10,10b, 21,85±5,13c) sugerindo que o efeito teratogênico da planta diminui durante o armazenamento. Conclui-se que as vagens de P. juliflora são teratogênicas para ratas Wistar e que a fetoxicidade das mesmas diminui com o armazenamento.(AU)

The objective of this study was to determine the possible teratogenic effects of Prosopis juliflora, check if there is a loss in toxicity between pods stored and newly collected and determine whether there are differences in toxicity between the pods collected in different localities. Thirty pregnant female Wistar rats were randomly separated into five groups: a control (G1) and four experimental (G2, G3, G4 and G5), each with six animals. The animals in groups G2 and G3 were fed diets containing 70% of pods of P. juliflora newly collected in two different municipalities. The groups G4 and G5 were fed beans prepared with the same origins, but stored for a period of 6 months. The control group received the same diet without pods of P. juliflora. In the control group the number of defects per litter (1.16 ± 0.98) was significantly lower than the experimental groups (14.00 ± 2.96, 6.16 ± 2.22, 7.66 ± 2.94 and 4.66 ± 1.63 for G2, G3, G4 and G5, respectively) indicating that the plant is teratogenic. No significant differences were observed in the frequency of malformations and number of fetuses born between groups receiving pods from different locations. However, the number of defects in the groups who received the freshly harvested pods was significantly different from the number observed in rats that received the beans after storage, suggesting that the teratogenic effect of the plant decreases during storage. We conclude that the pods of P. juliflora are teratogenic for Wistar rats and that the teratogenicity decreases with storage.(AU)

Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries

Objective: Pregnant women and their health care professionals commonly believe that use of medications during pregnancy may be harmful to the unborn fetus. The objective of this study was to evaluate the risk perception of psychotropic drug use in pregnancy among physicians in different medical specialties. Method: This was a convenience survey conducted at outpatient clinics in the cities of Recife, Brazil, and La Plata, Bahía Blanca, and Buenos Aires, Argentina. Physicians who agreed to participate were asked to rate their perception of teratogenic risk among different classes of drugs, which included antidepressants, antipsychotics, anticonvulsants, and benzodiazepines. Results: Two hundred and thirty-eight physicians completed the survey (response rate, 98%). These included psychiatrists, obstetricians, neurologists, cardiologists, gastroenterologists, and general practitioners. Among different specialties, a minority of psychiatrists perceived psychotropic drugs to be highly teratogenic (antidepressants, 12.5%; antipsychotics, 15%; benzodiazepines, 25%) as compared with other specialties (p < 0.003 for each drug class). There was no difference in perceived risk of antiepileptic drugs among specialties, including psychiatrists. Conclusion: The risk associated with use of psychotropic drugs in pregnancy was overestimated by physicians of all medical specialties, except psychiatry. All physicians should be aware of the safety/risk of psychotropic agents in pregnancy, as they may be required to give advice and/or prescribe these drugs to pregnant women. .

Chlorophyllin in the intra-uterine development of mice exposed or not to cyclophosphamide / Clorofilina no desenvolvimento intra-uterino de camundongos expostos ou não à ciclofosfamida

Chlorophyllin, a sodium-copper salt synthesized from chlorophyll, has already proved to have anticlastogenic, antimutagenic and anticarcinogenic activity, however few are the studies in the teratogenicity area. The present study evaluated the effects of chlorophyllin in intra- uterine development of mice exposed or not to cyclophosphamide. Pregnant females were divided into 8 groups of 15 animals each, G01 - PBS (0.1 mL 10.0-1 g) orally; G02 ­ cyclophosphamide (20.0 mg kg-1) i.p.; G03, G04 and G05 - chlorophyllin at concentrations of (5.0, 10.0 and 15.0 mg kg-1) orally; G06, G07 and G08 (5.0, 10.0 and 15.0 mg kg -1) orally, of chlorophyllin, respectively, and (20.0 mg kg-1) i.p. of cyclophosphamide. In the 18th day the females were submitted to laparotomy and females and fetuses analyzed. The results showed that the chlorophyllin was not effective in protecting the reproductive parameters as well as teratogenicity. Finally, it was observed that the presence of chlorophyllin increased the frequency of some malformations when combined with cyclophosphamide. However, it was not teratogenic and not embryo lethal in this experimental design.

Clorofilina é um sal de cobre e sódio sintetizado a partir da clorofila. Provou-se ter atividade anticlastogênica, antimutagênica e anticarcinogênica. No entanto, poucos são os estudos sobre esta substância na área de teratologia. Dessa forma, o presente trabalho avaliou os efeitos da clorofilina no desenvolvimento intrauterino de camundongos expostos ou não à ciclofosfamida. Para tal, fêmeas prenhez foram divididas em oito grupos experimentais contendo 15 animais cada: G01 - PBS (0,1 mL 10.0-1 g) via oral; G02 - ciclofosfamida (20,0 mg kg-1), intraperitoneal; G03, G04 e G05 - clorofilina em concentrações de (5,0; 10,0 e 15,0 mg kg-1) via oral; G06, G07 e G08 (5,0, 10,0 e 15,0 mg kg-1) via oral, de clorofilina, respectivamente, e 20,0 mg kg-1, via intraperitoneal, de ciclofosfamida. No 18º dia de gestação, os animais foram submetidos à laparotomia e os fetos, analisados para parâmetros teratogênicos. Os resultados mostraram que a clorofilina não foi eficaz para proteger os parâmetros reprodutivos, bem como a teratogenicidade. Finalmente, foi observado que a clorofilina quando combinada com a ciclofosfamida aumentou a frequência de algumas malformações. No entanto, a clorofilina não se apresentou teratogênica e nem letal para este desenho experimental.

New host records of Ixodes luciae (Acari: Ixodidae) in the State of Para, Brazil / Registros de novos hospedeiros para Ixodes luciae (Acari: Ixodidae) no estado do Pará, Brasil

The aim of this paper is to record new hosts for Ixodes luciae Sénevet in the State of Para, Brazil, and present a case of malformation (teratogeny) in a nymph of this species. The new host records are Marmosa murina (parasitized by females) and Philander opossum (parasitized by nymphs). One of these nymphs showed malformation in the posterior margin of the opisthosoma resulting in a heart shaped posterior end.

O objetivo deste trabalho foi registrar novos hospedeiros para Ixodes luciae Sénevet no estado do Pará, Brasil, e um caso de malformação em uma ninfa dessa espécie de carrapato. Os novos hospedeiros são Marmosa murina (parasitado por fêmeas) e Philander opossum (parasitado por ninfas). Uma dessas ninfas apresentou uma malformação na parte posterior do opistossoma em forma de coração.

[Teratogenic effects of Origanum Vulgare in mice fetals]

A number of studies on reproduction have mentioned Origanum Vulgare extract's ability to reduce mortality rates and improve fertility rates. However, other studies have suggested that it is possible to use Origanum Vulgare extract to induce abortion. The aim of this study was to investigate the effect of different doses of Origanum Vulgare on embryo survival and macroscopic abnormalities in mice. In this study, 24 mice Balb/c female weighting approximately 25-30 g were divided into 4 groups. Origanum Vulgare extract was prepared; different concentrations [2.5, 12.5, and 25 mg in 0.25 ml distilled water] were administered, by oral gavage, to three experimental groups of mice between day 6 [starting gastrulation] until day 15 of pregnancy [end of organogenesis]. The control group consisted of six mice that received 0.25 ml of distilled water daily. On day 16 of study, pregnant mice were anesthetized by chloroform and fetuses were removed and stained with Alcian Blue, Alizarin Red s and microwave irradiation. Morphological and skeletal abnormalities were investigated by light and stereomicroscopes. The results of this study showed that high doses of the Origanum Vulgare extract significantly decreased the mean number of embryos [10 +/- 0.5, P>0.05], mean number of live embryos [7 +/- 0.5, P>0.05] in each mouse and resulted in significant reduction in mean weight[1184 +/- 8 mg, P>0.05] and crown-rump length[11.9 +/- 0.23 mm, P>0.05] and the overall size of fetuses compared to control group, whereas there was no significant difference between the groups receiving low dose of Origanum Vulgare extract with control group. In addition, under the effect of the Origanum Vulgare extract the subcutaneous bleeding seemed [2 +/- 0.1, P>0.05] significantly more frequent compared to the control group. Origanum Vulgare extract did not have any positive effect on fetal development; and high dosages led to an increased incidence rate of abortion and fetal malformations in the fetuses of women who received it.

Efeito do extrato aquoso de camomila (Chamomilla recutita L. ) na prenhez de ratas e no desenvolvimento dos filhotes / Effect of aqueous extract of chamomile (Chamomilla recutita L. ) on rat pregnancy and offspring development

As plantas medicinais possuem substâncias ativas e, muitas vezes, o efeito tóxico sobre o organismo é desconhecido ou ignorado pelos usuários. A camomila é muito utilizada pela população, porém, contra-indicada para gestantes por possuir indícios de atividade emenagoga e relaxante da musculatura lisa. Por esses motivos, o objetivo do presente estudo foi avaliar os efeitos do extrato aquoso de camomila na gestação e nos filhotes gerados. Foram utilizadas 9 ratas da linhagem Wistar, divididas em 3 grupos, D1 e D2 que receberam infusão de camomila a 5% e 10% respectivamente, e o grupo controle que recebeu soro fisiológico. Os tratamentos foram administrados por via oral, desde o 1º ao 7º dia após o cruzamento. Os parâmetros estudados foram: prevalência de abortos, ganho de peso materno durante a prenhez, morte fetal e materna, malformações fetais grosseiras, número de recém-nascidos, peso dos filhotes, e análise de reflexos neurológicos dos filhotes (postural, preensão e orientação) no 1º, 3º, 5º e 10º dias de vida. Houve gestação em 70% do grupo controle, 40% do D1 e 80% do D2. Não houve diferença no ganho de peso materno no 7º e 21º dia, porém, os grupos tratados obtiveram ganho de peso menor em relação ao controle no 14º dia de gestação (p=0,04). As diferenças entre o número de recém-nascidos não foram significantes. Quanto ao peso dos recém-nascidos, os animais tratados apresentaram menor ganho de peso aos dias 1, 3, 5, e 10 após o nascimento (p=0,005; p=0,001; p<0,001; p<0,001; respectivamente). Ocorreram diferenças no reflexo postural no 1º dia, ocorrendo aceleração (p=0,005); já no reflexo de preensão (p=0,006), e no reflexo de orientação (p=0,01) houve retardo no desaparecimento, sem alteração nos demais dias sobre os outros parâmetros avaliados. A camomila pode influenciar, tanto no ganho de peso materno durante a gestação, como no dos filhotes após o nascimento, e pode provocar alterações nos reflexos neurológicos. Não se observou alteração nos demais parâmetros estudados.

Medicinal plants have active substances and their toxic effect on the organism is often unknown or ignored by users. Chamomile has been widely used by the population; however, it is contraindicated for pregnant women due to evidence of its emmenagogue and relaxing activity on smooth muscles. For these reasons, the aim of this study was to evaluate the effects of aqueous extract of chamomile on pregnancy and generated offspring. Nine Wistar rats were divided into three groups, D1 and D2, which received chamomile infusion at 5% and 10%, respectively, and the control group which received saline solution. Treatments were administered from the 1st to the 7th day after breeding. The studied parameters were abortion prevalence, maternal weight gain during pregnancy, fetal and maternal death, gross fetal malformation, newborn number, weight and neurological reflexes of the offspring on the 1st, 3rd, 5th and 10th days of life. There was pregnancy in 70% of control group, 40% of D1 and 80% of D2. There was no difference in maternal weight gain on the 7th and 21st days; however, treated groups had smaller weight gain, compared to control, on the 14th day of pregnancy (p=0.04). The differences among newborn numbers were not significant. As to weight of newborns, treated animals had smaller weight gain on days 1, 3, 5 and 10 after birth (p=0.005; p=0.001; p<0.001; p<0.001; respectively). For neurological effects, there were differences in postural reflex on the 1st day, resulting in acceleration; on the other hand, for grasp (p=0.006) and orienting reflex (p=0.01), there was a delay in disappearing, and no changes occurred on the remaining days for the other assessed parameters. Chamomile may influence maternal weight gain during pregnancy, as well as offspring weight gain after birth, and may cause changes in neurological reflexes. There was no alteration in the remaining studied parameters.